LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 158

Search options

  1. Article ; Online: Addressing Barriers to Provision of First-Line Pharmacotherapy for Tobacco Use Disorder.

    Evins, A Eden / Cather, Corinne

    Psychiatric services (Washington, D.C.)

    2022  Volume 74, Issue 4, Page(s) 429–430

    MeSH term(s) Humans ; Tobacco Use Disorder/drug therapy ; Smoking Cessation ; Bupropion/therapeutic use
    Chemical Substances Bupropion (01ZG3TPX31)
    Language English
    Publishing date 2022-11-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1220173-x
    ISSN 1557-9700 ; 1075-2730
    ISSN (online) 1557-9700
    ISSN 1075-2730
    DOI 10.1176/appi.ps.20220467
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial.

    Weiss, Jakob H / Tervo-Clemmens, Brenden / Potter, Kevin W / Evins, A Eden / Gilman, Jodi M

    Psychological assessment

    2023  Volume 35, Issue 8, Page(s) 659–673

    Abstract: The use of cannabis for medical symptoms is increasing despite limited evidence for its efficacy. Expectancies-prior beliefs about a substance or medicine-can modulate use patterns and effects of medicines on target symptoms. To our knowledge, cannabis ... ...

    Abstract The use of cannabis for medical symptoms is increasing despite limited evidence for its efficacy. Expectancies-prior beliefs about a substance or medicine-can modulate use patterns and effects of medicines on target symptoms. To our knowledge, cannabis expectancies have not been studied for their predictive value for symptom relief. The 21-item Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M) is the first longitudinally validated measure of expectancies for cannabis used for medical symptoms. The questionnaire was developed for a randomized clinical trial of the effect of state cannabis registration (SCR) card ownership on symptoms of pain, insomnia, anxiety, and depression in adults (
    MeSH term(s) Adult ; Humans ; Cannabis ; Psychometrics ; Sleep Initiation and Maintenance Disorders/diagnosis ; Surveys and Questionnaires ; Substance-Related Disorders
    Language English
    Publishing date 2023-06-08
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 1000939-5
    ISSN 1939-134X ; 1040-3590
    ISSN (online) 1939-134X
    ISSN 1040-3590
    DOI 10.1037/pas0001244
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cannabis use for medical symptoms: Patterns over the first year of use.

    Gilman, Jodi M / Potter, Kevin / Schuster, Randi M / Hoeppner, Bettina B / Evins, A Eden

    Addictive behaviors

    2023  Volume 144, Page(s) 107719

    Abstract: Background: As greater numbers of states in the United States and countries in the world continue to legalize cannabis for medical use, it has become increasingly important to assess patterns of cannabis use in individuals using cannabis for medical ... ...

    Abstract Background: As greater numbers of states in the United States and countries in the world continue to legalize cannabis for medical use, it has become increasingly important to assess patterns of cannabis use in individuals using cannabis for medical symptoms over time. A public health concern is that, like recreational cannabis, some individuals using cannabis for medical reasons may develop detrimental patterns of use, leading to the development of a cannabis use disorder (CUD).
    Methods: In a 9-month longitudinal cohort study following a 12-week randomized, waitlist-controlled trial in 149 adults who used cannabis to alleviate insomnia, pain, depressed mood, or anxiety (RCT: NCT03224468), we assessed whether patterns of cannabis use for the 9 months following the RCT were associated with the development of CUD.
    Results: We identified five unique trajectories of use; 31 participants (21%) had low stable or no use, 50 (34%) had medium stable use, 19 (13%) had high stable use, 26 (17%) showed de-escalating and 23 (15%) showed escalating use over 9 months following the RCT. Of 149 participants enrolled, 19 (13%) met diagnostic criteria for CUD at 12 months. Only the escalating cannabis use pattern predicted significantly higher rates of CUD compared to the low or no use category (OR = 4.29, 95% CI = 1.21 to 10.87, p = 0.02).
    Conclusions: These data indicate that most individuals using cannabis for medical symptoms have a stable pattern of use over the first year. Escalation of use may be a detrimental pattern that warrants further concern.
    MeSH term(s) Adult ; Humans ; United States/epidemiology ; Cannabis ; Marijuana Abuse/epidemiology ; Marijuana Abuse/diagnosis ; Longitudinal Studies ; Substance-Related Disorders ; Anxiety Disorders
    Language English
    Publishing date 2023-04-13
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 197618-7
    ISSN 1873-6327 ; 0306-4603
    ISSN (online) 1873-6327
    ISSN 0306-4603
    DOI 10.1016/j.addbeh.2023.107719
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Substance Use, Suicidal Thoughts, and Psychiatric Comorbidities Among High School Students.

    Tervo-Clemmens, Brenden / Gilman, Jodi M / Evins, A Eden / Bentley, Kate H / Nock, Matthew K / Smoller, Jordan W / Schuster, Randi M

    JAMA pediatrics

    2024  Volume 178, Issue 3, Page(s) 310–313

    MeSH term(s) Humans ; Adolescent ; Suicidal Ideation ; Substance-Related Disorders/epidemiology ; Substance-Related Disorders/psychology ; Suicide, Attempted/psychology ; Students/psychology ; Adolescent Behavior/psychology
    Language English
    Publishing date 2024-01-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701223-2
    ISSN 2168-6211 ; 2168-6203
    ISSN (online) 2168-6211
    ISSN 2168-6203
    DOI 10.1001/jamapediatrics.2023.6263
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity.

    Karunakaran, Keerthana Deepti / Pascale, Michael / Ozana, Nisan / Potter, Kevin / Pachas, Gladys N / Evins, A Eden / Gilman, Jodi M

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    2024  

    Abstract: Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within ...

    Abstract Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
    Language English
    Publishing date 2024-05-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 639471-1
    ISSN 1740-634X ; 0893-133X
    ISSN (online) 1740-634X
    ISSN 0893-133X
    DOI 10.1038/s41386-024-01876-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Impact of year-long cannabis use for medical symptoms on brain activation during cognitive processes.

    Burdinski, Debbie / Kodibagkar, Alisha / Potter, Kevin / Schuster, Randi / Evins, A Eden / Ghosh, Satrajit / Gilman, Jodi

    medRxiv : the preprint server for health sciences

    2024  

    Abstract: Importance: Cannabis is increasingly being used to treat medical symptoms, but the effects of cannabis use on brain function in those using cannabis for these symptoms is not known.: Objective: To test whether brain activation during working memory, ... ...

    Abstract Importance: Cannabis is increasingly being used to treat medical symptoms, but the effects of cannabis use on brain function in those using cannabis for these symptoms is not known.
    Objective: To test whether brain activation during working memory, reward, and inhibitory control tasks, areas of cognition impacted by cannabis, showed increases following one year of cannabis use for medical symptoms.
    Design: This observational cohort study took place from July 2017 to July 2020 and is reported on in 2024.
    Setting: Participants were from the greater Boston area.
    Participants: Participants were recruited as part of a clinical trial based on seeking medical cannabis cards for anxiety, depression, pain, or sleep disorders, and were between 18 and 65 years. Exclusion criteria were daily cannabis use and cannabis use disorder at baseline.
    Main outcomes and measures: Outcomes were whole brain functional activation during tasks involving working memory, reward and inhibitory control at baseline and after one year of cannabis use.
    Results: Imaging was collected in participants before and one year after obtaining medical cannabis cards; 57 at baseline (38 female [66.7%]; mean [SD] age, 38.0 [14.6] years) at baseline, and 54 at one-year (37 female [68.5%]; mean [SD] age, 38.7 [14.3] years). Imaging was also collected in 32 healthy control participants (22 female [68.8%]; mean [SD] age, 33.8 [11.8] years) at baseline. In all groups and at both time points, functional imaging revealed canonical activations of the probed cognitive processes. No statistically significant difference in brain activation between the two timepoints (baseline and one-year) in those with medical cannabis cards and no association of changes in cannabis use frequency with brain activation were found.
    Conclusions and relevance: Findings suggest that adults do not show significant neural effects in the areas of cognition of working memory, reward, and inhibitory control after one year of cannabis use for medical symptoms. The results warrant further studies that probe effects of cannabis at higher doses, with greater frequency, in younger age groups, and with larger, more diverse cohorts.Trial Registration: NCT03224468, https://clinicaltrials.gov/.
    Key points: Question::
    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.04.29.24306516
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Call to Action for Treatment of Comorbid Tobacco and Alcohol Dependence.

    Evins, A Eden / Kelly, John F

    JAMA psychiatry

    2018  Volume 75, Issue 2, Page(s) 121–122

    MeSH term(s) Alcoholism/epidemiology ; Cigarette Smoking ; Comorbidity ; Humans ; Nicotiana ; Varenicline
    Chemical Substances Varenicline (W6HS99O8ZO)
    Language English
    Publishing date 2018-03-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2701203-7
    ISSN 2168-6238 ; 2168-622X
    ISSN (online) 2168-6238
    ISSN 2168-622X
    DOI 10.1001/jamapsychiatry.2017.3542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Reassessing the safety of varenicline.

    Evins, A Eden

    The American journal of psychiatry

    2013  Volume 170, Issue 12, Page(s) 1385–1387

    MeSH term(s) Benzazepines/adverse effects ; Female ; Humans ; Male ; Quinoxalines/adverse effects ; Smoking Cessation/psychology ; Suicidal Ideation ; Tobacco Use Cessation Products/adverse effects ; Varenicline
    Chemical Substances Benzazepines ; Quinoxalines ; Varenicline (W6HS99O8ZO)
    Language English
    Publishing date 2013-12
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 280045-7
    ISSN 1535-7228 ; 0002-953X
    ISSN (online) 1535-7228
    ISSN 0002-953X
    DOI 10.1176/appi.ajp.2013.13091257
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution.

    Dotson, Samuel / Johnson-Arbor, Kelly / Schuster, Randi M / Tervo-Clemmens, Brenden / Evins, A Eden

    Addiction (Abingdon, England)

    2022  Volume 117, Issue 9, Page(s) 2371–2373

    MeSH term(s) Behavior, Addictive ; Cannabis ; Dronabinol ; Humans ; Psychotic Disorders
    Chemical Substances Dronabinol (7J8897W37S)
    Language English
    Publishing date 2022-03-24
    Publishing country England
    Document type Editorial
    ZDB-ID 1141051-6
    ISSN 1360-0443 ; 0965-2140
    ISSN (online) 1360-0443
    ISSN 0965-2140
    DOI 10.1111/add.15873
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence.

    Baumer, Andreas M / Nestor, Bridget A / Potter, Kevin / Knoll, Sarah / Evins, A Eden / Gilman, Jodi / Kossowsky, Joe / Schuster, Randi M

    Drug and alcohol dependence

    2023  Volume 252, Page(s) 110989

    Abstract: Background: Withdrawal from cannabis use is associated with sleep disturbances, often leading to resumption of use. Less is known about the impact of abstinence on sleep in adolescence, a developmental window associated with high rates of sleep ... ...

    Abstract Background: Withdrawal from cannabis use is associated with sleep disturbances, often leading to resumption of use. Less is known about the impact of abstinence on sleep in adolescence, a developmental window associated with high rates of sleep disturbance. This study investigated effects of sustained abstinence on self-reported sleep quality and disturbance in adolescents reporting frequent cannabis use.
    Methods: Non-treatment seeking adolescents, recruited from school screening surveys and the community, with frequent cannabis use (M
    Results: Participants in CB-Abst reported higher overall PSQI scores than those in CB-Mon (M=1.06, p=0.01) indicating worse sleep during the four-week trial. Sleep disruptions in CB-Abst increased during Week 1 of abstinence (d=0.34, p=0.04), decreased during Week 2 (d=0.36, p=0.04), and remained constant for the rest of the trial. At Week 4, sleep was comparable to baseline levels for those in CB-Abst (p=0.87). Withdrawal-associated sleep disruption in the CB-Abst group was circumscribed to increases in sleep latency (b=0.35; p=0.05).
    Conclusions: Cannabis abstinence in adolescents was associated with transient delayed onset of sleep initiation falling asleep during the first week of abstinence. Findings highlight withdrawal-associated changes in sleep latency as an intervention target for supporting adolescents attempting abstinence. Future research should use objective measures of sleep and focus on elucidating mechanisms underlying sleep disturbances with cannabis use and withdrawal.
    MeSH term(s) Humans ; Female ; Adolescent ; Male ; Cannabis ; Marijuana Abuse/complications ; Sleep ; Behavior Therapy ; Sleep Latency ; Substance Withdrawal Syndrome
    Language English
    Publishing date 2023-10-11
    Publishing country Ireland
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2023.110989
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top